Pathophysiology of leprosy: immunological response related to clinical forms
DOI:
https://doi.org/10.33448/rsd-v11i9.32058Keywords:
Leprosy; Mycobacterium leprae; Physiopathology; Leprosy Reaction.Abstract
The aim of this study is to elucidate the physiopathology of leprosy and relate it to its clinical forms through an narrative review. The search for articles was carried out in the LILACS, PUBMED, SCIELO, MEDLINE and VHL databases, and the following descriptors were used: Leprosy, Mycobacterium leprae, physiopathology and leprosy reaction. The search was restricted to studies published from 2013 until the year 2021, and articles related to the theme were selected. Leprosy presents a complex pathophysiology, correlated with different immune patterns, involving dendritic cells, pattern recognition receptors (PRRs), macrophages and natural killer (NK) cells, which will release interleukins that will determine the type of immune response of the host, among which we address Th1, Th2, Th17, T regulators (Treg), Th9, Th22 and others. When the cellular immune pattern is activated with a predominance of the Th1 pattern, the patient tends to progress to the benign pole (tuberculoid leprosy), if the specific cellular response is mild or absent to the antigens of the same agent, with a prevalence of the Th2 pattern and humoral response, the individual tends to the malignant pole (lepromatous leprosy) of the disease, as well as to the development of type 1 and type 2 leprosy reactions.
References
Aarão, T. L.; de Sousa, J. R.; Botelho, B. S.; Fuzii, H. T. & Quaresma, J. A. (2016). Correlation between nerve growth factor and tissue expression of IL-17 in leprosy. Microb Pathog., 90, 64-68. doi: 10.1016/j.micpath.2015.11.019.
Abreu, M. (2021). Hanseníase: cenário atual e perspectivas. Jornal Dermatológico - SBD-RESP. Ano 37, no 213. p. 9-15.
Andrade, F. A.; Beltrame, M. H.; Bini, V. B.; Gonçalves, L. B.; Boldt, A. B. & de Messias-Reason, I. J. (2017). Association of a new FCN3 haplotype with high ficolin-3 levels in leprosy. PLoS Negl Trop Dis., 11 (2), e0005409. doi: 10.1371/journal.pntd.0005409.
Antunes, D. E.; Goulart, I. M. B.; Lima, M. I. S.; Alves, P. T.; Tavares, P. C. B. & Goulart, L. R. (2019). Differential expression of IFN-γ, IL-10, TLR1, and TLR2 and their potential effects on downgrading leprosy reaction and erythema nodosum leprosum. J immunol Res., 7 (2019), 3405103. doi:10.1155/2019/3405103
Abulafia, A.L.; Avelleira, C. J.; Azulay, D. R.; Azulay, R.D. (2017). Micobacterioses. In: Azulay R. Dermatologia. 7. ed. Rio de Janeiro: Guanabara Koogam, 2017. p. 426-455.
Bhat, R. M.; Vaidya, T. P. (2020). What is new in the pathogenesis and management of erythema nodosum leprosum. Indian Dermatol Online J., 11 (4), 482-492.
de Sousa, J. R.; Lucena Neto, F. D.; Sotto, M. N. & Quaresma, J. A. S. (2018a). Immunohistochemical characterization of the M4 macrophage population in leprosy skin lesions. BMC Infect Dis., 18 (1), 576. doi: 10.1186/s12879-018-3478-x.
de Sousa, J. R.; Pagliari, C.; de Almeida, D. S. M.; Barros, L. F. L.; Carneiro, F. R. O.; Dias, Jr L. B., et al (2017b). Th9 cytokines response and its possible implications in the immunopathogenesis of leprosy. J Clin Pathol., 70 (6), 521-527. doi: 10.1136/jclinpath-2016-204110.
de Sousa, J.; Prudente, R.; Dias Junior, L.; Oliveira Carneiro, F.; Sotto, M. & Simões Quaresma, J. (2018b). IL-37 and leprosy: a novel cytokine involved in the host response to Mycobacterium leprae infection. Cytokine, 106, 89-94. doi: 10.1016/j.cyto.2017.10.016.
de Sousa, J.; Sotto, M. & Simões Quaresma, J. (2017a). Leprosy as a complex infection: breakdown of the Th1 and Th2 immune paradigm in the immunopathogenesis of the disease. Front Immunol, 8, 1635. doi: 10.3389/fimmu.2017.01635.
de Souza, V. (2014). Imunologia da Hanseníase. In E. Alves, T. Ferreira & I. Nery (Orgs.). Hanseníase: avanços e desafios. Brasília, DF: Núcleo de Estudos em Educação e Promoção da Saúde – NESPROM/UnB. p. 105-118.
Grant, M.J.; Booth, A. (2009). A typology of reviwes: an analysis of 14 review types and associated methodologies. Health Information and Libraries Journal., 26, pp91-108. doi: 10.1111/j.1471-1842.2009.00848.x
Lima, C. P.; Costa, E. M.; Sampaio, L. F. (2019). Expression of FoxP3 in different forms of leprosy and reactions. J Bras Patol Med Lab., 55 (4), 434-441. doi.org/10.5935/1676-244.20190040.
Medeiros, R. C.; Girardi, K. D.; Cardoso, F. K.; Mietto, B. S.; Pinto, T. G. & Gomez, L. S. (2016), et al. Subversion of Schwann cell glucose metabolism by Mycobacterium leprae. J Biol Chem., 291 (41), 21375-21387. doi: 10.1074/jbc.M116.725283.
Naafs, B. & van Hees, C. L. (2016). Leprosy type 1 reaction (formerly reversal reaction). Clin Dermatol., 34 (1), 37-50. doi: 10.1016/j.clindermatol.2015.10.006.
Organização Mundial da Saúde (2021). Estratégia global de hanseníase 2021–2030 – “Rumo à zero hanseníase”. https://www.who.int/pt/publications/i/item/9789290228509.
Parente, J. N.; Talhari, C.; Schettini, A. P. & Massone, C. (2015). T regulatory cells (TREG)(TCD4+CD25+FOXP3+) distribution in the different clinical forms of leprosy and reactional states. An Bras Dermatol., 90 (1), 41-47. doi: 10.1590/abd1806-4841.20153311.
Reibel, F.; Cambau, E. & Aubry, A. (2015). Update on the epidemiology, diagnosis, and treatment of leprosy. Med Mal Infect, 45 (9), 383-393. doi: 10.1016/j.medmal.2015.09.002.
Sadhu, S.; Khaitan, B. K.; Joshi, B.; Sengupta, U.; Nautiyal, A. K. & Mitra, D. K. 2016). Reciprocity between regulatory T cells and Th17 cells: relevance to polarized immunity in leprosy. PLoS Negl Trop Dis., 10 (1), e0004338. doi: 10.1371/journal.pntd.0004338.
Scollard, D.; Truman, R. & Ebenezer, G. (2015). Mechanisms of nerve injury in leprosy. Clin Dermatol, 33 (1), 46–54. doi:10.1016/j.clindermatol.2014.07.008.
Soares, C. T.; Rosa, P. S.; Trombone, A. P.; Fachin, L. R.; Ghidella, C. C.; Ura, S., et al. (2013). Angiogenesis and lymphangiogenesis in the spectrum of leprosy and its reactional forms. PLoS One, 8 (9), e74651. doi: 10.1371/journal.pone.0074651.
Talhari, C.; Talhari, S. & Penna, G. O. Clinical aspects of leprosy (2015). Clin Dermatol., 33 (1), 26–37. doi:10.1016/j.clindermatol.2014.07.002.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ana Cláudia Ferreira Yonemoto; Mario Ciro Choptian Júnior; Victor Augusto de Oliveira Mattara; Marilda Aparecida Milanez Morgado de Abreu
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
